Find-A-Study

A Global, Open-Label, Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients

Purpose

Category

Heart, Vascular and Blood
Lungs, Breathing and Bronchial

IRB Number: 20190423HU
NCT Number: -
Open to Enrollment: Yes
Sponsor: -

Study Contact

Karl Mccloskey
mccloskeyk@uthscsa.edu

Rodolfo Estrada Anzueto
(210) 617-5256
estradaanzue@uthscsa.edu

Principal Investigator
Rodolfo Estrada Anzueto

Rodolfo Estrada Anzueto
(210) 617-5256
estradaanzue@uthscsa.edu

Italia Herrera
(210) 567-2687
herrerai1@uthscsa.edu

Johnnie Jones
(210) 450-7277
jonesj21@uthscsa.edu

Deborah Levine
(210) 617-5256
levinedj@uthscsa.edu

Karl Mccloskey
mccloskeyk@uthscsa.edu

Lorannys Sanchez Tamarez
(210) 450-8332
sancheztamar@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups